Evidence map›Paper›PMID 32371185›Full record

ArticleEuropean journal of radiology2020

Impact of

Julian Kirchner, Ole Martin, Lale Umutlu, Ken Herrmann, Ann-Kathrin Bittner, Oliver Hoffmann, Swetlana Mohrmann, Thomas Gauler, Sarah Theurer, Christina Antke and 9 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Julian KirchnerDepartment of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, D-40225, Dusseldorf, Germany. Electronic address: Julian.Kirchner@med.uni-duesseldorf.de.
Ole MartinDepartment of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, D-40225, Dusseldorf, Germany.
Lale UmutluDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.
Ken HerrmannDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.
Ann-Kathrin BittnerDepartment Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.
Oliver HoffmannDepartment Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.
Swetlana MohrmannDepartment of Gynecology, University Dusseldorf, Medical Faculty, D-40225, Dusseldorf, Germany.
Thomas GaulerDepartment of Radiation Oncology, West German Cancer Center, University of Duisburg-Essen Medical School, Hufelandstr. 55, 45122, Essen, Germany.
Sarah TheurerInstitute of Pathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany.
Christina AntkeDepartment of Nuclear Medicine, University Dusseldorf, Medical Faculty, D-40225, Dusseldorf, Germany.
Irene EspositoInstitute of Pathology, Medical Faculty, Heinrich-Heine-University and University Hospital Duesseldorf, Duesseldorf, Germany.
Sonja KinnerDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.
Benedikt M SchaarschmidtDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, D-45147, Essen, Germany.
Bernd KowallInstitute of Medical Informatics, Biometry and Epidemiology, Essen University Medical Center, Essen, Germany.
Diana Lütke-BrintrupInstitute of Medical Informatics, Biometry and Epidemiology, Essen University Medical Center, Essen, Germany.
Andreas StangInstitute of Medical Informatics, Biometry and Epidemiology, Essen University Medical Center, Essen, Germany.
Anton S BeckerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Gerald AntochDepartment of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, D-40225, Dusseldorf, Germany.
Christian BuchbenderDepartment of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, D-40225, Dusseldorf, Germany.
Heinrich Heine University Düsseldorf · DEUniversity of Duisburg-Essen · DEInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DEDeutschen Konsortium für Translationale Krebsforschung · DEMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeTo investigate whether potential differences in staging between a traditional staging imaging algorithm and

methodIn this prospective cohort study from two university hospitals 56 women with newly diagnosed, therapy-naive breast cancer and increased pre-test probability for distant metastases were included. All patients were examined by a traditional staging imaging algorithm (X-ray mammography, breast ultrasonography, chest plain radiography, bone scintigraphy, and ultrasonography of the liver and axillary fossa) and whole-body

resultsStaging by

conclusionIn conclusion, for breast cancer patients with elevated pre-test probability for distant metastases a change of the therapy regiment occurs in 14 % of patients when staged by

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsAdultAgedAged, 80 and overAlgorithmsBreastBreast NeoplasmsCohort StudiesFemaleHumansMagnetic Resonance ImagingMiddle AgedMultimodal ImagingNeoplasm StagingPositron-Emission TomographyFluorodeoxyglucose F18RadiopharmaceuticalsBreast cancerMagnetic Resonance Imagingpositron emission tomographyTNM staging

Identifiers

PMID32371185
PMCPMC9587896
OpenAlexW3018384456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.